Banner MD Anderson Cancer Center ( Site 0028) — Gilbert, Arizona

Public research footprint of Banner MD Anderson Cancer Center ( Site 0028), compiled from the ClinicalTrials.gov public registry.

279

Registered studies

140

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Carcinoma, Non-Small-Cell Lung · Breast Neoplasms · Diffuse Large B-Cell Lymphoma · Multiple Myeloma

Recently updated registry entries

NCT03055013 — Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy (Active Not Recruiting)
NCT01274338 — Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage… (Active Not Recruiting)
NCT04267848 — Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Banner MD Anderson Cancer Center ( Site 0028)?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.